An alternative pathway for metabolism of leukotriene D4: effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea
- 1 August 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 133 (7) , 1134-1144
- https://doi.org/10.1038/sj.bjp.0704180
Abstract
Contractions of guinea-pig tracheal preparations to cysteinyl-leukotrienes (LTC(4), LTD(4) and LTE(4)) were characterized in organ baths, and cysteinyl-leukotriene metabolism was studied using radiolabelled agonists and RP-HPLC separation. In the presence of S-hexyl GSH (100 microM) the metabolism of [(3)H]-LTC(4) into [(3)H]-LTD(4) was inhibited and the LTC(4)-induced contractions were resistant to CysLT(1) receptor antagonism but inhibited by the dual CysLT(1)/CysLT(2) receptor antagonist BAY u9773 (0.3 - 3 microM) with a pA(2)-value of 6.8+/-0.2. In the presence of L-cysteine (5 mM), the metabolism of [(3)H]-LTD(4) into [(3)H]-LTE(4) was inhibited and the LTD(4)-induced contractions were inhibited by the CysLT(1) receptor antagonist ICI 198,615 (1 - 10 nM) with a pA(2)-value of 9.3+/-0.2. However, at higher concentrations of ICI 198,615 (30 - 300 nM) a residual contraction to LTD(4) was unmasked, and this response was inhibited by BAY u9773 (1 - 3 microM). In the presence of the combination of S-hexyl GSH with L-cysteine, the LTD(4)-induced contractions displayed the characteristics of the LTC(4) contractile responses, i.e. resistant to CysLT(1) receptor antagonism, increased maximal contractions and slower time-course. This qualitative change of the LTD(4)-induced contraction was also observed in the presence of S-decyl GSH (100 microM), GSH (10 mM) and GSSG (10 mM). S-hexyl GSH, S-decyl GSH, GSH and GSSG all stimulated a formation of [(3)H]-LTC(4) from [(3)H]-LTD(4). In conclusion, GSH and GSH-related compounds changed the pharmacology of the LTD(4)-induced contractions by stimulating the conversion of LTD(4) into LTC(4). Moreover, the results indicate that, in addition to the metabolism of LTC(4) into LTD(4) and LTE(4), also the formation of LTC(4) from LTD(4) may regulate cysteinyl-leukotriene function.Keywords
This publication has 36 references indexed in Scilit:
- Characterization of the Human Cysteinyl Leukotriene 2 ReceptorJournal of Biological Chemistry, 2000
- The Molecular Characterization and Tissue Distribution of the Human Cysteinyl Leukotriene CysLT2 ReceptorBiochemical and Biophysical Research Communications, 2000
- The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileumEuropean Journal of Pharmacology, 1996
- BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypesEuropean Journal of Pharmacology, 1994
- Characterization of sulfidopeptide leukotriene responses in sheep tracheal smooth muscle in vitroCanadian Journal of Physiology and Pharmacology, 1991
- Endogenously formed leukotriene C4 activates LTC4 receptors in guinea pig tracheal stripsEuropean Journal of Pharmacology, 1991
- Evidence for two leukotriene receptor types in the guinea-pig isolated ileumEuropean Journal of Pharmacology, 1990
- Characteristics of formation and further metabolism of leukotrienes in the chopped human lungBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Metabolism of cysteinyl leukotrienes in non‐recirculating rat liver perfusionEuropean Journal of Biochemistry, 1989
- How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?Journal of Pharmacy and Pharmacology, 1978